VI-1121
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VI-1121, covering 2013-12-11 to 2013-12-11. Get the full timeline:
Most recent: Clinical Trial Update: VI-1121 for the Treatment Alzheimer's Disease [Phase 2]